While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid ...
FDA commissioner Robert Califf’s second term is anticipated to end in 2025, and all eyes are now on who will be the ...
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...
Kennedy has a history of vaccine disinformation and suggested a ban on fluoride in water and eliminating entire FDA ...
At a cancer research event Tuesday, FDA Commissioner Robert Califf said he was “disappointed” with the election results ...
Trump has promised he would allow Robert F. Kennedy Jr. to "go wild" on medicines, food, and health. With that, a radical antiestablishment medical movement with roots in past centuries could threaten ...
Federal employees are concerned over President-elect Donald Trump’s pick, Robert F. Kennedy Jr., to lead the Department of ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...